Connect Sign In
ARUP has published the Summer 2026 edition of Magnify, which highlights applied AI in lab medicine, patient impact, and strategies to help health systems and labs thrive.
ARUP supports the bipartisan RESULTS Act, which would reform Medicare lab testing reimbursement policy, protect patient access to testing, and create a more stable system for clinical laboratories.
After years of itchy, red bumps that made her skin feel as if ants were crawling across it, Misty Segrest has her life back—thanks in part to ultrasensitive laboratory testing and targeted treatment.
Adam Barker, PhD, ARUP’s chief operations officer and president of the Reference Business Unit, shares how science, leadership, and fatherhood shaped his people‑first approach.
An inside look at three ARUP labs—Mass Spec 1, Exception Handling, and Immunohistochemistry—showing how teamwork, innovation, and behind-the-scenes dedication support accurate testing and care.
Tracy George, MD, ARUP chief scientific officer and Innovation Business Unit president, will help advance life sciences innovation and strengthen Utah’s healthcare ecosystem with BioUtah.
ARUP will expand its AI-augmented screening tool for the detection of human gastrointestinal parasites to become first and only lab to apply AI to the entire ova and parasite testing process.
Dan Albertson, MD, president of ARUP’s University Business Unit, aims to rely on his and his colleagues’ clinical practice and expertise to continuously improve care for patients at University of Utah Health and Huntsman Cancer Institute and to share the knowledge gained with hospitals and health…
FDA leaders answered questions on artificial intelligence (AI), international regulations, and representation in clinical trials during the Utah Life Sciences Summit.
ARUP has been awarded a CDC contract for avian influenza A (H5N1) test development, which recognizes our expertise and experience with assay development and our desire to serve public health needs.
